Contributing to global tuberculosis control through innovative research and training:
From Bench to Bedside and Beyond.

Read More

Subscribe to the JHU-CTB mailing list!

Where we Work

Events

TB Clinical and Epidemiology Lunch Meeting

Time: Every Thursday at 12:20pm - 1:20pm

Cancer Research Building 2, 1550 Orleans St, 1M.13
Baltimore, MD

Click for More Information

Updates

Costs and Consequences of Using Interferon-γ...

There is growing concern that interferon-γ release assays (IGRAs) are being used off-label for the diagnosis of active...

Read More

Clofazimine Contributes Sustained...

Experimental and clinical studies have indicated that the antileprosy drug clofazimine may contribute treatment-shortening...

Read More

Antibiotics. Targeting DnaN for tuberculosis...

The discovery of Streptomyces-produced streptomycin founded the age of tuberculosis therapy. Despite the subsequent...

Read More

Outcomes of multi-drug resistant tuberculosis...

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients with human...

Read More

Cathepsin K Contributes to Cavitation and...

Cavitation in tuberculosis enables highly efficient person-to-person aerosol transmission. We performed transcriptomics in the...

Read More